Roche Diagnostics Corp. Class II

Company: Roche Diagnostics Corp.
Date of Enforcement Report: 1/21/04
Class: II

PRODUCT
a) Roche brand OMNI 7 clinical chemistry analyzer; catalog
numbers GD0435 and GD0435R. Recall # Z-0326-04;
b) Roche brand OMNI 8 clinical chemistry analyzer; catalog
numbers GD0455 and GD0455R. Recall # Z-0327-04;
Roche brand OMNI 9 clinical chemistry analyzer; catalog
numbers GD0475, GD0475R and GD047591.
Recall # Z-0328-04.

REASON
If the sample volume is insufficient, the analyzer may issue erroneous results without any indication to the user that the problem is insufficient sample volume.

CODE
All units with software version 5.61 or below.

RECALLING FIRM/MANUFACTURER
Roche Diagnostics Corp., Indianapolis, IN, by letter on or about December 15, 2003. FDA initiated recall is ongoing.

VOLUME OF PRODUCT IN COMMERCE
131.

DISTRIBUTION
Nationwide.

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other Emerging Standards Impacting Medical Device Software

Being Agile & Yet Compliant

ISO 14971 SaMD Risk Management

Software Risk Management

Medical Device Cybersecurity

Software Verification

IEC 62366 Usability Process and Documentation

Or just email training@softwarecpr.com for more info.

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.